43 filings
6-K
MITO
Stealth BioTherapeutics Corp
16 Nov 22
Stealth BioTherapeutics Corp Announces Completion of Merger
4:08pm
6-K
MITO
Stealth BioTherapeutics Corp
7 Oct 22
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
4:10pm
6-K
MITO
Stealth BioTherapeutics Corp
30 Sep 22
Current report (foreign)
5:10pm
6-K
MITO
Stealth BioTherapeutics Corp
19 Aug 22
Current report (foreign)
4:15pm
6-K
MITO
Stealth BioTherapeutics Corp
1 Aug 22
Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction
8:38am
6-K
qrzsxpvkbe6cg
11 Jul 22
Stealth Biotherapeutics Announces Receipt of Non-compliance Notice from Nasdaq
5:20pm
6-K
bymztea9
27 Jun 22
Stealth BioTherapeutics Corp Announces Receipt of Preliminary
8:02am
6-K
j2eg1621jnw6s7 m2
18 May 22
Current report (foreign)
8:16am
6-K
t6zctom8mj t91
11 Apr 22
Current report (foreign)
8:41am
6-K
gbgd0e98t2
18 Mar 22
Current report (foreign)
4:46pm
6-K
h9ha0l 7v0iq1mb0
14 Feb 22
Stealth Biotherapeutics Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Requirement
12:00am
6-K
kn0ptzhvonhpdsg
7 Jan 22
Stealth Biotherapeutics Receives Nasdaq Notifications Regarding Minimum Bid and Market Value Requirements
4:40pm
6-K
kxyzvk emgvovfp0re
12 Nov 21
Stealth Biotherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
8:15am
6-K
zbs101v th6c9t8
20 Oct 21
Current report (foreign)
7:50am
6-K
07lrl5mfrcofm0eon9jp
4 Oct 21
Current report (foreign)
7:45am
6-K
n5iufmr jemf
5 Aug 21
Current report (foreign)
4:47pm
6-K
aj5o21a1
5 Aug 21
Stealth Biotherapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights
8:10am
6-K
8ewbbp9tu 0k2669d4
20 Jul 21
6-K Annual Meeting Results
4:11pm
6-K
z1gvnzse8r
15 Jun 21
6-K for Annual Proxy
4:30pm
6-K
enzoso
18 May 21
Stealth Biotherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials
8:21am